Cargando…

RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer

BACKGROUND: Aberrant expression of DNA repair pathways such as homologous recombination (HR) can lead to DNA repair imbalance, genomic instability, and altered chemotherapy response. DNA repair imbalance may predict prognosis, but variation in DNA repair in diverse cohorts of breast cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walens, Andrea, Van Alsten, Sarah C., Olsson, Linnea T., Smith, Markia A., Lockhart, Alex, Gao, Xiaohua, Hamilton, Alina M., Kirk, Erin L., Love, Michael I., Gupta, Gaorav P., Perou, Charles M., Vaziri, Cyrus, Hoadley, Katherine A., Troester, Melissa A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720427/ https://www.ncbi.nlm.nih.gov/pubmed/36129803 http://dx.doi.org/10.1158/1055-9965.EPI-22-0590

Ejemplares similares

Diffsig: Associating Risk Factors With Mutational Signatures
por: Park, Ji-Eun, et al.
Publicado: (2023)

DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma
por: Smith, Markia A., et al.
Publicado: (2022)

Incorporating RNA-based Risk Scores for Genomic Instability to Predict Breast Cancer Recurrence and Immunogenicity in a Diverse Population
por: Hamilton, Alina M., et al.
Publicado: (2023)

Protein-based immune profiles of basal-like vs. luminal breast cancers
por: Walens, Andrea, et al.
Publicado: (2021)

Hepatocyte growth factor pathway expression in breast cancer by race and subtype
por: Jones, Gieira S., et al.
Publicado: (2021)

Prediction of Toxicant-Specific Gene Expression Signatures after Chemotherapeutic Treatment of Breast Cell Lines
por: Troester, Melissa A., et al.
Publicado: (2004)

TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study
por: Hurson, Amber N., et al.
Publicado: (2022)

Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases
por: Hurson, Amber N., et al.
Publicado: (2022)

Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay
por: Hurson, Amber N., et al.
Publicado: (2023)

Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression
por: Fassler, Danielle J., et al.
Publicado: (2022)

Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study
por: Parada, Humberto, et al.
Publicado: (2017)

Predicting early breast cancer recurrence from histopathological images in the Carolina Breast Cancer Study
por: Shi, Yifeng, et al.
Publicado: (2023)

Gene expression patterns associated with p53 status in breast cancer
por: Troester, Melissa A, et al.
Publicado: (2006)

The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregation
por: Wang, Yilin, et al.
Publicado: (2023)

Impact of stromal microenvironment on metabolic phenotypes in breast cancer: evidence for stroma-influenced Warburg effect
por: Brauer, Heather Ann, et al.
Publicado: (2012)

Molecular Features of Androgen-Receptor Low, Estrogen Receptor-Negative Breast Cancers in the Carolina Breast Cancer Study
por: Jinna, Nikita, et al.
Publicado: (2023)

DeCompress: tissue compartment deconvolution of targeted mRNA expression panels using compressed sensing
por: Bhattacharya, Arjun, et al.
Publicado: (2021)

Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
por: Jinna, Nikita D., et al.
Publicado: (2023)

Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological Features
por: Benefield, Halei C, et al.
Publicado: (2020)

Identification of drug targets for the treatment of Basal-like tumors
por: Hoadley, KA, et al.
Publicado: (2005)

The Cancer/Testes (CT) Antigen HORMAD1 promotes Homologous Recombinational DNA Repair and Radioresistance in Lung adenocarcinoma cells
por: Gao, Yanzhe, et al.
Publicado: (2018)

Simplified Gene Knockout by CRISPR-Cas9-Induced Homologous Recombination
por: Dalvie, Neil C., et al.
Publicado: (2021)

Genomic characterization of rare molecular subclasses of hepatocellular carcinoma
por: Damrauer, Jeffrey S., et al.
Publicado: (2021)

Structural basis of homologous recombination
por: Sun, Yueru, et al.
Publicado: (2019)

A framework for transcriptome-wide association studies in breast cancer in diverse study populations
por: Bhattacharya, Arjun, et al.
Publicado: (2020)

Identification of mRNA isoform switching in breast cancer
por: Zhao, Wei, et al.
Publicado: (2016)

Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer
por: Patel, Achal, et al.
Publicado: (2022)

Integrated RNA and DNA sequencing improves mutation detection in low purity tumors
por: Wilkerson, Matthew D., et al.
Publicado: (2014)

EGFR associated expression profiles vary with breast tumor subtype
por: Hoadley, Katherine A, et al.
Publicado: (2007)

Malaria parasites utilize both homologous recombination and alternative end joining pathways to maintain genome integrity
por: Kirkman, Laura A., et al.
Publicado: (2014)

Homologous recombination and its regulation
por: Krejci, Lumir, et al.
Publicado: (2012)

BRCA2 and homologous recombination
por: Orelli, Brian J, et al.
Publicado: (2001)

Homologous Recombination: To Fork and Beyond
por: Prado, Félix
Publicado: (2018)

The Regulation of Homologous Recombination by Helicases
por: Huselid, Eric, et al.
Publicado: (2020)

BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance
por: Nacson, Joseph, et al.
Publicado: (2018)

Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer
por: Thorner, Aaron R., et al.
Publicado: (2010)

Determinants of Homologous Recombination Deficiency in Pancreatic Cancer
por: Wattenberg, Max M., et al.
Publicado: (2021)

Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer
por: Damrauer, Jeffrey S., et al.
Publicado: (2021)

TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases
por: Williams, Lindsay A., et al.
Publicado: (2018)

Targeting homologous recombination deficiency in uterine leiomyosarcoma
por: Dall, Genevieve, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_34mb2dj8nl2hhr5qnmt7oiccd6